Table 3.
Discussions about ADs at the end of life
| Number of paediatricians who held discussions | p Value | ||
| Neurologists (n=186) |
Haematologists (n=227) |
||
| Adolescent patients | |||
| Cardiopulmonary resuscitation | |||
| Use of: | |||
| Ventilator | 99 (57) | 70 (31) | <0.01 |
| Vasopressor | 73 (42) | 54 (24) | <0.01 |
| Antibiotics | 62 (36) | 47 (21) | <0.01 |
| Tube-feeding | 88 (51) | 90 (40) | <0.01 |
| Intravenous fluids | 74 (43) | 74 (33) | 0.03 |
| Family | |||
| Cardiopulmonary resuscitation | 162 (93) | 215 (99) | 0.10 |
| Use of: | |||
| Ventilator | 170 (97) | 213 (98) | 0.60 |
| Vasopressor | 156 (89) | 192 (88) | 0.34 |
| Antibiotics | 131 (76) | 115 (53) | <0.01 |
| Tube-feeding | 145 (83) | 160 (74) | 0.10 |
| Intravenous fluids | 131 (75) | 140 (65) | 0.04 |
Data are presented as n (%). Percentage was calculated based on the number of respondents for each item.
p Values were calculated by logistic regression adjusted for sex, postgraduate experience and number of dying patients <18 years of age cared for.
AD, advance directives.